Ibidreid

Colecalciferol, the active ingredient in Ibidreid, is a vitamin D analog presented as an oral tablet for oral use. It is used to treat vitamin D deficiency and support bone health in children and adults.

GNH USA supplies Ibidreid as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ibidreid (colecalciferol) is used to address conditions related to vitamin D deficiency and bone metabolism.

- Vitamin D deficiency: restores adequate serum 25‑hydroxyvitamin D levels. - Rickets: prevents bone softening and deformities in children. - Osteomalacia: improves bone mineralization in adults. - Bone health maintenance: supports calcium absorption for overall skeletal health.

Common Side Effects: - Hypercalcemia: elevated blood calcium levels causing fatigue or nausea. - Nausea: mild stomach upset after oral intake. - Constipation: reduced bowel movements. - Headache: occasional mild headache. - Dry mouth: sensation of oral dryness. - Fatigue: feeling unusually tired.

Serious or Rare Side Effects: - Severe hypercalcemia: may lead to cardiac arrhythmia. - Hypercalciuria: excess calcium in urine, risk of kidney stones. - Renal stones: formation of calcium‑based stones in kidneys. - Allergic reactions: rash, itching, or swelling. - Hypervitaminosis D: toxicity from excessive vitamin D levels. - Acute pancreatitis: very rare inflammatory pancreas condition.

Before initiating therapy, consider patient-specific factors and monitor appropriately. - Baseline assessment: check serum calcium and 25‑hydroxyvitamin D levels. - Renal function: adjust use in patients with impaired kidney function. - Hypercalcemia: avoid in individuals with existing high calcium levels. - Sarcoidosis or granulomatous disease: use with caution due to altered vitamin D metabolism. - Store at room temperature: keep in the original pack, protect from moisture and light.

Colecalciferol may interact with several medicines that affect calcium balance.

Major Interactions (Avoid): - Thiazide diuretics: increase risk of hypercalcemia. - High-dose vitamin A supplements: synergistic hypercalcemia risk. - Calcium supplements: may cause excessive calcium accumulation.

Moderate Interactions (Monitor Closely): - Anticonvulsants (e.g., phenytoin, phenobarbital): accelerate vitamin D metabolism, reducing efficacy. - Glucocorticoids: decrease calcium absorption, may require dose adjustment. - Orlistat: reduces intestinal absorption of fat‑soluble vitamins, including vitamin D.